Barinthus Biotherapeutics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Barinthus Biotherapeutics is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.44. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	$ 334.00K	$ 468.00K	$ 6.46M	$ 6.17M
Gross Profit	-	$ 334.00K	$ 468.00K	$ 6.46M	-
EBIT	$ -18.10M	$ -24.95M	$ -21.48M	$ -24.58M	$ 6.83M
EBITDA	$ -16.67M	-	$ -20.26M	$ -23.40M	$ 8.02M
Net Income Common Stockholders	$ -45.47M	$ -23.80M	$ -18.18M	$ -21.19M	$ 8.24M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 142.09M	$ 173.03M	$ 191.33M	$ 194.38M	$ 200.10M
Total Assets	$ 214.51M	$ 246.13M	$ 261.82M	$ 270.20M	$ 275.48M
Total Debt	$ 12.98M	$ 12.18M	$ 10.65M	$ 8.77M	$ 8.26M
Net Debt	$ -129.11M	$ -160.85M	$ -180.67M	$ -185.61M	$ -191.85M
Total Liabilities	$ 27.51M	$ 28.67M	$ 28.25M	$ 27.00M	$ 31.33M
Stockholders Equity	$ 186.78M	$ 217.21M	$ 233.30M	$ 242.90M	$ 243.84M
Cash Flow	-
Free Cash Flow	$ -19.45M	-	$ -5.77M	$ -11.93M	$ 9.48M
Operating Cash Flow	$ -19.60M	-	$ -3.26M	$ -11.34M	$ 11.88M
Investing Cash Flow	$ 153.00K	-	$ -2.42M	$ -586.00K	$ -2.02M
Financing Cash Flow	$ 109.00K	-	$ 1.69M	$ 484.00K	$ 0.00

Currency in USD

Barinthus Biotherapeutics Earnings and Revenue History

Income Statement >

Barinthus Biotherapeutics Debt to Assets

Balance Sheet >

Barinthus Biotherapeutics Cash Flow

Cash Flow >

Barinthus Biotherapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing